It's Deja Vu for this Ultra-High-Yield Dividend Stock as 2025 Starts With a Similar Challenge as Last Year

business people have a meeting about company statistics
It's Deja Vu for this Ultra-High-Yield Dividend Stock as 2025 Starts With a Similar Challenge as Last Year

Medical Properties Trust (NYSE: MPW) got off to a challenging start last year. In January, the real estate investment trust (REIT) revealed that its top tenant at the time, Steward Health Care, was experiencing liquidity issues, which impacted its ability to pay rent.

Steward filed for bankruptcy a few months later. The year ended more positively as the REIT was able to take control of its real estate from Steward and lease most of those properties to five higher-quality replacement operators.

With Steward no longer in the picture, the healthcare REIT thought it had finally closed the door on its tenant issues last year. Unfortunately, that wasn't the case. It recently revealed that another leading tenant, Prospect Medical Group, has filed for bankruptcy .

New year, same issue

Prospect Medical Group filed for bankruptcy in early January. The healthcare company has been experiencing liquidity issues, due partly to the stalled sales processes across several East Coast markets (Rhode Island, Connecticut, and Pennsylvania). The REIT has investments linked to Prospect in two of those states (Connecticut and Pennsylvania). It also has investments in California.

Medical Properties Trust had previously recapitalized its $1.6 billion investment with Prospect in May 2023, which included:

As a result of its liquidity issues, Prospect hasn't paid any rent to Medical Properties Trust on the California hospital since last June, even though those facilities reported volume growth and improved coverage trends last year. Meanwhile, it has only made minimal payments related to leases and mortgages in Connecticut and Pennsylvania over the past two years.

Working to preserve and recover value

Medical Properties Trust received some positive news regarding its investment in Prospect late last year. The company announced that Astrana Health had agreed to buy a majority of Prospect's managed-care platform for $745 million plus the assumption of some liabilities in November. As a result, Medical Properties Trust expects to receive about $200 million, with most of that cash expected in the first half of this year (it will also receive a $50 million payment by 2027).

However, with Prospect filing for bankruptcy, the REIT's focus is now on protecting its California hospital investment. Medical Properties Trust also anticipates that the process will enable Prospect to successfully complete the sale of its Connecticut facilities . This outcome would enable it to recoup some of the value of its Connecticut properties while resuming rent collection in California.

Given that the REIT currently isn't collecting any income from these properties right now , the bankruptcy likely won't have any impact on its dividend (which currently yields 7.7%). Instead, its rental income is on track to rise this year as the new tenants at its former Steward facilities start making rental payments.

Those payments will steadily escalate over the next two years, reaching their fully stabilized rate at the end of 2026 (about 95% of Steward's lease rate). That growing income stream could enable Medical Properties Trust to rebuild its dividend following two deep cuts in recent years.

Two steps forward and another back

Medical Properties Trust continues to battle tenant-related headwinds. While it has finally severed its relationship with Steward, Prospect has become a source of trouble again.

However, its bankruptcy could enable Prospect to finally sell off its troubled East Coast operations so that it can focus on California, which would benefit Medical Properties Trust. The hope is that it will quickly reemerge from bankruptcy, which could finally enable Medical Properties Trust to put its tenant issues in the past. That would allow the company to focus on rebuilding its portfolio, dividend, and shareholder value.

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

See 3 “Double Down” stocks »

OK